Mizuho Lowers Envision Healthcare Corporation (NYSE:EVHC) Price Target to $57.00
Envision Healthcare Corporation (NYSE:EVHC) had its target price cut by Mizuho from $65.00 to $57.00 in a research note issued on Wednesday. The firm presently has a “neutral” rating on the stock. Mizuho’s price objective suggests a potential upside of 2.61% from the stock’s current price.
Other equities research analysts also recently issued reports about the company. Royal Bank Of Canada reaffirmed a “buy” rating and set a $72.00 price objective on shares of Envision Healthcare Corporation in a report on Monday, June 5th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $80.00 price objective on shares of Envision Healthcare Corporation in a report on Tuesday, July 4th. Zacks Investment Research raised Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 price objective on the stock in a report on Tuesday, July 4th. Jefferies Group LLC set a $75.00 price objective on Envision Healthcare Corporation and gave the company a “buy” rating in a report on Friday, April 21st. Finally, Canaccord Genuity reaffirmed a “buy” rating and set a $86.00 price objective on shares of Envision Healthcare Corporation in a report on Tuesday, April 18th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $71.56.
Envision Healthcare Corporation (NYSE:EVHC) traded down 1.10% on Wednesday, reaching $54.94. The company’s stock had a trading volume of 809,029 shares. The stock’s 50 day moving average is $59.98 and its 200-day moving average is $61.58. Envision Healthcare Corporation has a 52 week low of $53.12 and a 52 week high of $74.75. The firm’s market capitalization is $6.38 billion.
Envision Healthcare Corporation (NYSE:EVHC) last released its earnings results on Monday, August 7th. The company reported $0.79 earnings per share for the quarter, topping analysts’ consensus estimates of $0.75 by $0.04. The business had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.96 billion. Envision Healthcare Corporation had a positive return on equity of 5.66% and a negative net margin of 7.35%. The firm’s revenue for the quarter was up 156.7% compared to the same quarter last year. During the same period last year, the business earned $0.34 earnings per share. Analysts predict that Envision Healthcare Corporation will post $1.40 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “Mizuho Lowers Envision Healthcare Corporation (NYSE:EVHC) Price Target to $57.00” was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.dailypolitical.com/2017/08/09/mizuho-lowers-envision-healthcare-corporation-nyseevhc-price-target-to-57-00.html.
In other news, insider Robert Jon Coward sold 1,500 shares of Envision Healthcare Corporation stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $62.69, for a total value of $94,035.00. Following the completion of the transaction, the insider now owns 97,863 shares in the company, valued at $6,135,031.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 3.10% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Livforsakringsbolaget Skandia Omsesidigt purchased a new position in Envision Healthcare Corporation during the first quarter worth about $135,000. Korea Investment CORP purchased a new position in Envision Healthcare Corporation during the first quarter worth about $141,000. Ameritas Investment Partners Inc. purchased a new position in Envision Healthcare Corporation during the first quarter worth about $172,000. First Interstate Bank purchased a new position in Envision Healthcare Corporation during the first quarter worth about $184,000. Finally, Daiwa Securities Group Inc. boosted its position in Envision Healthcare Corporation by 60.9% in the first quarter. Daiwa Securities Group Inc. now owns 3,169 shares of the company’s stock worth $194,000 after buying an additional 1,200 shares during the period. Institutional investors own 64.75% of the company’s stock.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.